September 8, 2025 · Form 4 insider transaction
Elsbernd Brian sold 30,000 shares of Cameron Pharmaceutical Inc at $20.30 per share, a transaction worth $609.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
The shares reported as sold herein and in Table I to the Reporting Person's Form 4 filed with the SEC on September 5, 2025 were sold on the open market to fund the exercise price and tax withholding due from Mr. Elsbernd on the exercise of the 112,475 stock options reported in Table II hereto and the 50,000 stock options reported on Table II to the Reporting Person's Form 8-K filed with the SEC on September 5, 2025.; Represents a weighted average price for the shares sold. Shares were sold in a range from $20.225 to $20.315 per share.